Introduction {#Sec1}
============

The development of time-lapse imaging technology has enabled consecutive observation of fertilization events, embryonic cleavage, compaction, and blastulation under stable and uninterrupted conditions, thus allowing the selection of appropriate embryos for transfer \[[@CR1]--[@CR7]\]. Several studies that have utilized time-lapse systems have reported that blastomere movement (BMov) occurs after the first cell division in human embryos \[[@CR8], [@CR9]\]. A recent study reported that BMov type (bouncing, wobbling, or twist-and-crumble) and duration vary markedly among embryos \[[@CR10]\]. Furthermore, this study showed BMov duration to be correlated with the incidence of asymmetric division, fragment generation, and ongoing pregnancy rate after fresh cleaved-embryo transfer on day 2. Therefore, BMov is considered a prognostic parameter for outcome prediction following cleavage-stage embryo transfer. However, it is not known whether BMov correlates with blastocyst formation and pregnancy outcome after blastocyst transfer. We evaluated the association between the BMov type and duration (dBMov) post first cell division and preimplantation development and live birth rates (LBRs) after blastocyst transfer.

Materials and methods {#Sec2}
=====================

Study population and design {#Sec3}
---------------------------

We retrospectively analyzed the clinical records of 966 cleaved embryos from 634 treatment cycles of 634 women who underwent oocyte retrieval during clomiphene citrate-based minimal-stimulation cycle, and which were scheduled for planned freeze-all strategy at the blastocyst stage at Kato Ladies Clinic between April 2017 and May 2018. Oocytes were inseminated by intracytoplasmic sperm injection (ICSI). The patients' own oocytes were used during treatment. The patients presenting with recurrent implantations; i.e., those who had previously undergone embryo transfer four or more times, were excluded from the study \[[@CR11]\]. In addition, patients who underwent preimplantation genetic diagnosis and women with hypothalamus-pituitary gland-related amenorrhea were excluded. Embryos that were directly cleaved from the 1- to 3-cell stage at the first cleavage were excluded from annotation.

Analysis of Blastomere movement {#Sec4}
-------------------------------

The detailed protocol for minimal stimulation with clomiphene citrate, ICSI, and embryo culture has been previously reported \[[@CR10], [@CR12]\]. The time points at which the second (t2) and third cells (t3) were completely separated by confluent membranes was annotated using the EmbryoScope+® time-lapse system, according to a previous report \[[@CR6]\]. The type of BMov after the first cell division was monitored, as previously reported \[[@CR10]\]. The dBMov between the first (t2) and second cell divisions (t3) was annotated, and the ratio of dBMov to the duration of the 2-cell stage (t3-t2) was calculated as dBMov/(t3-t2). The type of BMov was categorized into blastomere bouncing, wobbling, and twist-and-crumble groups, as previously reported \[[@CR10]\]. In brief, when blastomeres temporally shrank and then expanded immediately after the first cell division, blastomere movement was categorized as "bouncing". Cytoplasmic and membrane waving/distortion, which was reflected by a continuous change in the blastomere shape after t2, was defined as blastomere "wobbling". Blastomere rolling followed by fragment generation was defined as "twist-and-crumble". All annotations in the Embryo Viewer software and conventional morphological grading of embryos were performed by four blinded operators with more than 10 years of experience in embryology, who were unaware of the clinical outcomes.

Blastocyst transfer {#Sec5}
-------------------

Single vitrified-warmed blastocyst transfers (SVBTs) were performed, as previously reported \[[@CR12]\]. Dydrogesterone (30 mg/d) was administered orally during the early luteal phase after blastocyst transfer. In cases with insufficient luteal function, progesterone was administered intramuscularly (125 mg/d) or intravaginally (300--800 mg/d) until the 9th week of pregnancy. The clinical-pregnancy and ongoing-pregnancy rate (CPR and OPR, respectively) and LBR were analyzed.

Statistical analysis {#Sec6}
--------------------

All statistical analyses were performed using JMP software (SAS Institute, Cary, NC, USA). Proportion data were analyzed using the chi-square test or Cochran-Armitage test. Continuous parameters were compared via one-way analysis of variance (ANOVA), with significance determined using Tukey's test for post-hoc analysis. Logistic regression was used to assess the contributing strength of parameters that are potentially associated with pregnancy outcome. Spearman's Rank Correlation Coefficient (SRCC) was used to measure the degree of association between two continuous variables. Adjusted odds ratios were reported with 95% confidence intervals for each group. A value of *P* \<  0.05 was considered statistically significant.

Results {#Sec7}
=======

Patient characteristics are shown in Table [1](#Tab1){ref-type="table"}. The characteristics and clinical outcomes of the embryos are shown in Table [2](#Tab2){ref-type="table"}. The proportions of embryos with bouncing, wobbling, and twist-and-crumble movements were 56.2, 20.1, and 23.7%, respectively. Mean dBMov was 3.84 ± 0.07 h, and the value of dBMov/(t3-t2) was 0.366 ± 0.007. The type of blastomere movement was not correlated with age of the female (bouncing, 39.1 ± 0.2; wobbling, 39.2 ± 0.2; and twist-and-crumble, 38.8 ± 0.2, *P* = 0.4746) or the male (bouncing, 41.0 ± 0.2; wobbling, 41.5 ± 0.4; and twist-and-crumble, 41.0 ± 0.4, *P* = 0.2547). Furthermore, dBMov was not associated with the patient's age (SRCC: female age, 0.0135, *P* = 0.6820; male age, 0.0551, *P* = 0.0942) and dBMov ratio (SRCC: female age, 0.030, *P* = 0.3516; male age, 0.0576, *P* = 0.0743) were not associated with the patient's age.Table 1Patient characteristics (*n* = 634)Age (years) Female39.2 ± 0.1 \[27--47\] Male41.1 ± 0.2 \[25--64\]No. of previous embryo transfer cycles1.62 ± 0.03 \[0--3\]BMI21.2 ± 0.1 \[15.7--33.7\]Cause of infertility Ovulation7 (1.1) Tubal factor15 (2.4) Endometrial factor45 (7.1) Male factor110 (17.4) Combined29 (4.6) Unexplained428 (67.5)Continuous data are presented as mean ± standard error of the mean \[range\], categorical data are presented as n (%). Abbreviations: *BMI* body mass indexTable 2Analyzed embryo characteristics and clinical outcomesBlastomere movement typeTotalBouncingWobblingTwist-and-crumbleNo. of cleaved embryos analyzed966543 (56.2)194 (20.1)229 (23.7) Four-cell stage embryos964 (99.8)543 (100)194 (100)228 (99.6) Eight-cell stage embryos900 (93.2)516 (95.0)^a^181 (93.3)^a^202 (88.2)^b^ Morula842 (87.2)493 (90.8)^a^167 (86.1)^a,b^180 (78.6)^b^ Blastocysts731 (75.7)435 (80.1)^a^144 (74.2)^a,b^152 (66.4)^b^ Blastocysts expanded681 (70.5)406 (74.8)^a^136 (70.1)^a,b^139 (60.7)^b^ Blastocysts cryopreserved625 (64.7)378 (69.6)^a^124 (63.9)^a^123 (53.7)^b^ Morphological grade of blastocysts  ICM   Grade A291 (46.6)184 (48.7)59 (47.6)48 (39.0)   Grade B214 (34.2)129 (34.1)37 (29.8)48 (39.0)   Grade C120 (19.2)65 (17.2)28 (22.6)27 (22.0)  TE   Grade A267 (42.7)177 (46.8)^a^56 (45.2)^a^34 (27.6)^b^   Grade B178 (28.5)97 (25.7)^a^35 (28.2)^a,b^46 (37.4)^b^   Grade C180 (28.8)104 (27.5)33 (26.6)43 (35.0)No. of blastocysts thawed49929810299No. of survived blastocysts496 (99.3)297 (99.7)101 (99.0)98 (99.0)No. of blastocysts transferred49629710198Morphological grade of blastocysts transferred  ICM   Grade A250 (50.3)157 (52.7)52 (51.5)41 (41.8)   Grade B158 (31.9)90 (30.4)33 (32.7)35 (35.7)   Grade C88 (17.8)50 (16.9)16 (15.8)22 (22.5)  TE   Grade A235 (47.3)155 (52.0)^a^50 (49.5)^a^30 (30.6)^b^   Grade B128 (25.9)65 (22.0)^a^27 (26.7)^a,b^36 (36.7)^b^   Grade C133 (26.9)77 (26.0)24 (23.8)32 (32.7)Clinical pregnancies234 (47.2)136 (45.8)47 (46.5)51 (52.0)Ongoing pregnancies201 (40.5)115 (38.7)41 (40.6)45 (45.9)Follow-up data on live birth (ET date: April--December 2017)2461495344 Live birth88 (35.8)52 (34.9)18 (34.0)18 (40.9)dBMov3.84 ± 0.07 \[0.16--25.54\]2.82 ± 0.05^a^ \[0.16--8.49\]5.20 ± 0.13^b^ \[0.734--14.57\]5.36 ± 0.17^b^ \[0.63--25.54\]dBMov/(t3-t2)0.366 ± 0.007 \[0.014--1.000\]0.253 ± 0.004^a^ \[0.014--0.727\]0.497 ± 0.015^b^ \[0.071--1.000\]0.523 ± 0.016^b^ \[0.061--1.000\]Categorical data are presented as n (%), continuous data are presented as mean ± standard error of the mean \[range\]. Different superscript letters (a, b) indicate a significant difference at *P* \<  0.05. Abbreviations: dBMov, blastomere movement duration; dBMov/(t3-t2), ratio of the duration of blastomere movement at the 2-cell stage; ICM, inner cell mas; ET, embryo transfer; TE, trophectoderm

Embryos categorized with bouncing movement exhibited significantly higher developmental rates to the 8-cell, morula, blastocyst, and expanded-blastocyst stages than embryos with twist-and-crumble movement, especially from the 4-cell to the morula stage (Table [2](#Tab2){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}). To adjust for potential statistical confounding bias, a multivariate logistic regression analysis was also performed. Multivariate logistic regression analysis also indicated low developmental rates in the twist-and-crumble group (Table [3](#Tab3){ref-type="table"}). In contrast, the developmental rates were comparable between embryos with bouncing and wobbling movements. Furthermore, the morphological quality of the trophectoderm (TE) of embryos with twist-and-crumble movement was significantly lower than that of embryos with bouncing and wobbling movements, although the quality of the inner cell mass (ICM) was comparable among all groups (Table [2](#Tab2){ref-type="table"}). The CPR, OPR, and LBR after SVBT were comparable among groups (Table 2). Multivariate logistic regression analysis also showed that movement type was not associated with OPR or LBR (Table [3](#Tab3){ref-type="table"}).Table 3Adjusted odds ratio of blastomere movement type for embryonic development and pregnancy outcomesOutcomeMovement typeAdjusted odds ratio (95% CI)*P* valueExpanded blastocyst^a^BouncingReference--Wobbling0.763 (0.526--1.112)0.1584Twist-and-crumble0.476 (0.339--0.668)\< 0.0001Ongoing pregnancy^b^BouncingReference--Wobbling1.182 (0.701--1.993)0.5316Twist-and-crumble1.514 (0.799--2.342)0.1505Live birth^b^BouncingReference--Wobbling1.303 (0.598--2.838)0.5048Twist-and-crumble1.295 (0.566--2.967)0.5405Notes: ^a^Confounding factors: female age, male age, and body mass index. ^b^Confounding factors: female age, male age, body mass index, number of previous embryo transfer cycles, and blastocyst morphological grade. Abbreviations: *CI* confidence interval

Multivariate logistic regression analysis revealed that an increased value of dBMov/(t3-t2) was significantly correlated with decreased developmental rates to the 8-cell, morula, blastocyst, and expanded blastocyst stages, especially from the 4-cell to the morula stage (Table [4](#Tab4){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}). No correlation was observed between the value of dBMov/(t3-t2) and morphological quality of ICM (Grade A, 0.344 ± 0.011; B, 0.343 ± 0.014; C, 0.375 ± 0.021; *P* = 0.3065) or TE (Grade A, 0.335 ± 0.011; B, 0.359 ± 0.016; C, 0.363 ± 0.016; *P* = 0.0.2677). The CPR, OPR, and LBR were not correlated with the value of dBMov/(t3-t2) (Table [4](#Tab4){ref-type="table"}).Table 4Adjusted odds ratio of the value of dBMov/(t3-t2) for embryonic development and pregnancy outcomesOutcomesAdjusted odds ratio (95% CI)*P* valueFour-cell stage embryos^a^0.131 (0.008--2.294)0.1951Eight-cell stage embryos^a^0.265 (0.095--0.784)0.0132Morula^a^0.274 (0.123--0.624)0.0017Blastocysts^a^0.345 (0.176--0.678)0.0019Blastocysts expanded^a^0.415 (0.217--0.794)0.0077Clinical pregnancy^b^1.697 (0.659--4.368)0.2711Ongoing pregnancy^b^1.578 (0.398--5.554)0.5357Live birth^b^1.543 (0.321--6.946)0.5773Notes: ^a^Confounders: female age, male age, and body mass index. ^b^Confounders: female age, male age, body mass index, number of previous embryo transfer cycles, and blastocyst morphological grade. Abbreviations: *CI* confidence interval

Embryos were stratified into four groups according to the value of dBMov/(t3-t2): group A, dBMov/(t3-t2) \< 0.217; group B, 0.217 ≤ dBMov/(t3-t2) \< 0.300; group C, 0.300 ≤ dBMov/(t3-t2) \< 0.420; and group D, 0.420 ≤ dBMov/(t3-t2) (Table [5](#Tab5){ref-type="table"}). The cut-off values for group designation were determined using statistical software. The developmental rates to expanded blastocyst stage decreased significantly from group A to group D, and the Cochran-Armitage test confirmed a significant trend of declining expanded blastocyst rate with increasing dBMov/(t3-t2) value (*P* \< 0.0001). On the other hand, the CPR, OPR and LBR were not correlated with the dBMov/(t3-t2) value.Table 5Embryonic and pregnancy outcomes after single vitrified-warmed blastocyst transfer, stratified by the value of dBMov/(t3-t2)No. of embryosFemale ageMale ageBlastocystsExpanded blastocystsNo. of blastocysts transferredClinical pregnancyOngoing pregnancyFollow-up data on live birthLive birthGroup A \[dBMov/(t3-t2) \< 0.217\]20839.1 ± 0.241.0 ± 0.4170 (81.7)^a^165 (79.3)^a^12158 (47.9)48 (39.7)7227 (37.5)Group B \[0.217 ≤ dBMov/(t3-t2) \< 0.300\]24339.2 ± 0.241.2 ± 0.3190 (78.2)^a^178 (73.3)^a,\ b^12562 (49.6)56 (44.8)6221 (33.9)Group C \[0.300 ≤ dBMov/(t3-t2) \< 0.420\]23238.9 ± 0.240.6 ± 0.3178 (76.7)^a^160 (69.0)^b,\ c^11851 (43.2)42 (35.6)5519 (34.6)Group C \[0.420 ≤ dBMov/(t3-t2)\]28339.1 ± 0.241.4 ± 0.4193 (68.2)^b^178 (62.9)^c^13263 (47.7)55 (41.7)5721 (36.8)Categorical data are presented as n (%), continuous data are presented as mean ± standard error of the mean. Abbreviations: dBMov/(t3-t2), duration of blastomere movement during the 2-cell stage. Different superscript letters indicate a significant difference at *P* \< 0.05

Discussion {#Sec8}
==========

This study demonstrates that embryos, those with twist-and-crumble movement, have a lower developmental rate after the 4-cell stage and poor morphological quality of the trophectoderm at the blastocyst stage. The poor trophectoderm morphology of twist-and-crumble embryos may influence the cumulative pregnancy rate, although the present study revealed no statistical correlation between the twist-and-crumble movement and pregnancy outcome after SVBT. Blastomere polarization in preimplantation embryos plays an important role in the patterning of embryos and proper embryonic development. In humans, disrupted polarization is associated with significantly reduced blastocyst formation and implantation rates \[[@CR13]\]. We observed that the twist-and-crumble movement occurred concurrently with blastomere rolling. Although it is not known whether the twist-and-crumble movement interferes with or corrects cell polarity, our results suggest a potential association between improper blastomere polarization and decreased development in embryos with twist-and-crumble movement.

We have previously demonstrated that the prolongation of BMov is negatively associated with pregnancy outcomes following cleavage-stage embryo transfer on day 2; this extended BMov was associated with the delay of pronuclear fading and first cell division \[[@CR10]\]. The present study also showed significant correlations between prolonged BMov and decreased blastocyst formation rates. The cytoskeleton plays a key role in organelle transport, segregation of chromosomes, cell division, motility, and signaling, which are crucial steps in cell cycle progression \[[@CR14]\]. The distribution of cytoskeletal components is markedly changed in the cytoplasm of zygotes during the postfertilization period, and cytoskeletal reorganization after the first cell division is related to the success of embryonic development \[[@CR15]\]. Therefore, prolongation of blastomere movement after the first cell division can be caused by abnormal cytoplasmic activity with respect to cytoskeleton modification and reorganization, which negatively affects subsequent blastocyst development. The LBRs following SVBT were not affected by BMov type or duration in the present study, suggesting that BMov is not correlated with pregnancy outcomes once transferable expanded blastocysts are produced and transferred. However, the correlation between blastocyst development and BMov duration rationalizes our previous finding of prolonged BMov being negatively correlated with pregnancy outcomes after cleavage-stage embryo transfer \[[@CR10]\].

Conclusions {#Sec9}
===========

The present study provides evidence that BMov after the first cell division significantly predicts blastocyst formation. Therefore, taken together with our previous findings, we suggest that analysis of BMov is effective for predicting pregnancy outcome after cleaved-embryo transfer on days 2 and 3, but not after blastocyst transfer on day 5. However, this study is limited by its retrospective nature; thus, further randomized controlled trial studies are required to validate our findings.

Additional file
===============

 {#Sec10}

Additional file 1:Blastomere movement and embryonic development in each stage. (DOCX 21 kb)
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